This leaflet answers some common questions about DAPA-TABS. It is not to be used in relation to any other product, which may also contain the same active ingredient. It does not contain all of the ...

25 in Chicago and simultaneously published in the NEJM. In the first trial of an SGLT2 inhibitor for valvular disease, DAPA-TAVI was conducted at 39 centers across Spain, from January 2021 to December ...

The Defense Acquisition Program Administration (DAPA) has upgraded the UH-60 helicopter simulator used by the South Korean Army, enhancing its training capabilities for tactical and emergency ...

Treatment of severe heart failure (HF) across the spectrum of LVEF with the SGLT2 inihbitor dapagliflozin appeared to be safe and effective in reducing the risk of cardiovascular death or worsening HF ...